about
SCUBE3 is an endogenous TGF-β receptor ligand and regulates the epithelial-mesenchymal transition in lung cancerHuman pulmonary dirofilariasis coexisting with intercostal neurilemmoma: a case report and literature reviewThymidylate synthase and dihydrofolate reductase expression in non-small cell lung carcinoma: the association with treatment efficacy of pemetrexed.Identification of a novel FN1-FGFR1 genetic fusion as a frequent event in phosphaturic mesenchymal tumourKRAS mutation is a predictor of oxaliplatin sensitivity in colon cancer cellsSingle-Tube Reaction Using Perfluorocarbons: A Prerequisite Step Leading to the Whole-Slide In Situ Technique on Histopathological SlidesGSK3β controls epithelial-mesenchymal transition and tumor metastasis by CHIP-mediated degradation of SlugPhotodynamic therapy with topical 5-aminolevulinic acid as a post-operative adjuvant therapy for an incompletely resected primary nasopharyngeal papillary adenocarcinoma: a case report.Thoracic solitary fibrous tumor: clinical and pathological diversity.Expansile kaposiform hemangioendothelioma deformed thoracic cage in an adult.High PD-L1 expression is associated with stage IV disease and poorer overall survival in 186 cases of small cell lung cancers.Clinicopathological features and prognosis of patients with de novo versus nevus-associated melanoma in Taiwan.Lung adenocarcinoma patients of young age have lower EGFR mutation rate and poorer efficacy of EGFR tyrosine kinase inhibitors.A clinicopathological analysis of 153 acral melanomas and the relevance of mechanical stressIncluding total EGFR staining in scoring improves EGFR mutations detection by mutation-specific antibodies and EGFR TKIs response predictionCollapsin response mediator protein-1 and the invasion and metastasis of cancer cells.Phosphorylation of LCRMP-1 by GSK3β promotes filopoda formation, migration and invasion abilities in lung cancer cellsThe motor protein KIF14 inhibits tumor growth and cancer metastasis in lung adenocarcinomaSurgical treatment of a primary tracheal angiosarcoma.Oxaliplatin-based chemotherapy is more beneficial in KRAS mutant than in KRAS wild-type metastatic colorectal cancer patients.Surgical treatment for pulmonary aspergilloma: a 28 year experience.Circulating mRNA Profiling in Esophageal Squamous Cell Carcinoma Identifies FAM84B As A Biomarker In Predicting Pathological Response to Neoadjuvant ChemoradiationVascular leiomyoma of the head and neck.Diffuse pulmonary infiltrates after bone marrow transplantation: the role of open lung biopsy.Insulin-Like Growth Factor II mRNA-Binding Protein 3 Expression Correlates with Poor Prognosis in Acral Lentiginous Melanoma.Sinus pericranii: from gross and neuroimaging findings to different pathophysiological changes.The Effect of Radiotherapy on Ultrasound-Guided Fine Needle Aspiration Biopsy and the Ultrasound Characteristics of Neck Lymph Nodes in Oral Cancer Patients after Primary TreatmentMitochondrial translocation of EGFR regulates mitochondria dynamics and promotes metastasis in NSCLCExcellent survival of pediatric dermatofibrosarcoma protuberans in Taiwanese.Roles of Fhit and p53 in Taiwanese surgically treated non-small-cell lung cancersPrognostic factors for pulmonary metastasectomy in hepatocellular carcinoma.MDA-9/Syntenin-Slug transcriptional complex promote epithelial-mesenchymal transition and invasion/metastasis in lung adenocarcinoma.Oxaliplatin-based Chemotherapy Might Provide Longer Progression-Free Survival in KRAS Mutant Metastatic Colorectal Cancer.A new prognostic histopathologic classification of nasopharyngeal carcinoma.The mechanism of acquired resistance to irreversible EGFR tyrosine kinase inhibitor-afatinib in lung adenocarcinoma patientsMalignancies of the ear in irradiated patients of nasopharyngeal carcinoma.The Role of PIK3CA Mutations among Lung Adenocarcinoma Patients with Primary and Acquired Resistance to EGFR Tyrosine Kinase Inhibition.Thymectomy for non-thymomatous myasthenia gravis: a comparison of surgical methods and analysis of prognostic factors.Pulmonary manifestations and management of proteus syndrome.Tumor satellite in predicting occult nodal metastasis of tongue cancer.
P50
Q24298176-CC78FF7C-7FF3-4DC1-A5CA-8ADF7FEE4271Q27021971-ECDA5F98-495F-4952-862F-75A5EDF4350AQ27851625-41D35A75-B3C6-4162-830C-94F22048DD08Q28249787-41D2009F-5894-455B-A7AC-57D05CFE9190Q28485355-49EACD8B-33B9-47F6-8930-AB9AF2314648Q28552104-396FFC2B-1994-49AE-8D7D-98A79470F270Q30583575-680D6A6B-66E0-4995-A63E-E69895FE1CA5Q33233626-AFFE81BE-B413-470D-803A-E63FD1FB2F42Q33328335-D158C55E-B5AF-4B4B-A1EB-3BE380EB05AFQ33411255-8A8CA330-1573-4172-8E1A-A812B6855965Q33566790-DA3B3057-A376-4273-8691-3F8F8B020F2AQ33638140-A813D1F2-CE18-4888-AB20-200D5A30E6B0Q33638140-E680DEA0-77A3-4F96-8EF1-EB014BFF3D03Q33897441-099A942B-D81A-41AC-8F8E-B8BCECAC4B4FQ33912190-08E3F151-8980-4FDA-B750-C96CC8B2F237Q33999412-9B82F37B-6D95-42DF-8962-234CD3E96C1BQ34091667-0C234CD5-6F13-4760-AA56-C0262F691D63Q34171261-100B226E-0CB4-4E82-8B16-F5CA3970B99AQ34692260-258813CE-C9CC-4E08-8ABB-0C0F695D64E4Q35049934-810567F0-26F0-49EC-90D2-30F4852EEFEDQ35088086-926B7973-968B-40C1-B152-05639AE79558Q35563833-89D9D6D9-2DD3-4F92-97AB-025C8ECEC16EQ35616720-C9484B2F-EF4F-4AB2-B603-30F94B4F1A23Q35738370-86D396F5-2CB6-426E-A444-3246E1E7DAAAQ35820849-D15B5065-A6CB-456E-9A35-D403AAB7C80AQ35900481-69A43A9C-E87F-478E-A080-2827E6063139Q35921015-BF262043-A8D3-4118-B1C0-2E6F3F93F57FQ35949383-7076863C-2C57-4264-A20A-E55D858AE977Q36545739-CC8D2C5C-4AE6-4E83-8AC1-5578BCFD5431Q36655001-2E0F9608-EF95-4A19-9CA6-3E2AAD000032Q36670950-7CB6BADE-93D2-4C83-8EE5-E0065662AF80Q36676097-4225DFC2-F52D-45DD-B4FF-0EC0D45E92EDQ36729428-C5BE1E4B-9EE9-4901-8A9C-AB6072AD84D3Q36865085-C92DC9E8-6A10-4C7D-8052-92AFEDBEA182Q36871850-7C4081E7-99C7-48D5-87C7-07A719342CEBQ37022191-0C2A2061-A97C-4769-9772-CB3EB194F462Q37307478-CAA701B5-D229-4ACE-A466-9F6604CE7A05Q37335920-8BE86982-A711-42B1-A534-33D51BBEBB6EQ37555206-BA474C47-B5B4-4757-B653-D33FFCD247A0Q37760343-65436550-A68D-447A-844F-D76B29BDF7E0
P50
description
researcher
@en
wetenschapper
@nl
հետազոտող
@hy
name
Yih-leong Chang
@ast
Yih-leong Chang
@en
Yih-leong Chang
@es
Yih-leong Chang
@nl
Yih-leong Chang
@sl
type
label
Yih-leong Chang
@ast
Yih-leong Chang
@en
Yih-leong Chang
@es
Yih-leong Chang
@nl
Yih-leong Chang
@sl
altLabel
張逸良
@en
prefLabel
Yih-leong Chang
@ast
Yih-leong Chang
@en
Yih-leong Chang
@es
Yih-leong Chang
@nl
Yih-leong Chang
@sl
P106
P1153
7501844032
P31
P496
0000-0001-5309-0554